Influenza vaccine effectiveness in the 2011-2012 season: Protection against each circulating virus and the effect of prior vaccination on estimates

Clinical Infectious Diseases

Volumn 58, Issue 3, 2014, Pages 319-327

  Ohmit, Suzanne E ^a   Thompson, Mark G ^b   Petrie, Joshua G ^a   Thaker, Swathi N ^b   Jackson, Michael L ^c   Belongia, Edward A ^d   Zimmerman, Richard K ^e   Gaglani, Manjusha ^f,g   Lamerato, Lois ^h   Spencer, Sarah M ^b   Jackson, Lisa ^c   Meece, Jennifer K ^d   Nowalk, Mary Patricia ^e   Song, Juhee ^f,g   Zervos, Marcus ^h   Cheng, Po Yung ^b   Rinaldo, Charles R ^e   Clipper, Lydia ^f   Shay, David K ^b   Piedra, Pedro ⁱ   Monto, Arnold S ^a   more..

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d MARSHFIELD CLINIC   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^g TEXAS A M COLLEGE OF MEDICINE   (United States)

^h HENRY FORD HEALTH SYSTEM   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

ambulatory care; influenza; medically attended influenza; vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEASON; SENSITIVITY ANALYSIS; YOUNG ADULT;

AMBULATORY CARE; INFLUENZA; MEDICALLY ATTENDED INFLUENZA; VACCINE EFFECTIVENESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84892775673     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit736     Document Type: Article

References (30)

1. Russell CA, Jones TC, Barr IG, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008; 26:D31-4.
2. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morbid Mortal Wkly Rep 2010; 59.
3. Food and Drug Administration. FDA approves first quadrivalent vaccine to prevent seasonal influenza. Available at: www.fda.gov/News Events/Newsroom/ PressAnnouncements/ucm294057.htm. Accessed 5 March 2013.
4. Osterholm MT, Kelley NS, Sommer A, Belongia E. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
5. Griffin MR, Monto AS, Belongia EA, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011; 6:e23085.
6. Treanor J, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
7. Kissling E, Valenciano M, Cohen JM, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One 2011; 6:e27622.
8. Fielding JE, Grant KA, Tran T, Kelly HA. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Euro Surveillance 2012; 17:11.
9. Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012; 55:333-42.
10. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-9
11. CDC Flu View 2011-2012. Available at: www.cdc.gov/flu/weekly/weekly archives2011-2012/weekly39.htm. Accessed 5 March 2013.
12. Singh-Manoux A, Martikainen P, Ferrie J, Zins M, Marmot M, Goldberg M. What does self rated health measure? Results from the British Whitehall II and French Gazel cohort studies. J Epidemiol Community Health 2006; 60:364-72.
13. Van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ. The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS One 2011; 6:e17030.
14. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morbid Mortal Wkly Rep 2011; 60:1128-32.
15. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 19:2165-8.
16. Orenstein EW, de Serres G, Haber MJ, et al. Methodological issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31.
17. European Commission. Proposal for a Council recommendation on seasonal influenza vaccination. Available at: http://ec.europa.eu/health/ph-threats/com/ influenza/docs/seasonflu-rec2009-en.pdf. Accessed 25 March 2013.
18. Ferdinands JM, Shay DK. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. Clin Infect Dis 2012; 54:25-32.
19. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Wkly Epidemiol Rec 2011; 86:81-91.
20. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. MMWR Morbid Mortal Wkly Rep 2012; 61:613-8.
21. Beyer WEP, Palache AM, Sprenger MJW, et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996; 14:1331-9.
22. Sasaki S, He XS, Holmes TH, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 2008; 3:e2975.
23. Huijskens E, Rossen J, Mulder P, et al. Immunogenicity, boostability and sustainability of the immune response after vaccination against influenza A virus (H1N1) 2009 in a healthy population. Clin Vaccine Immunol 2011; 18:1401-5.
24. Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination; a meta-analysis of serologic and field studies. Arch Intern Med 1999; 159:182-8.
25. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15:1114-22.
26. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci 1999; 96:14001-6.
27. McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004; 78:12817-28.
28. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010; 28:2149-56.
29. Walter EB, Neuzil KM, Zhu Y, et al. Influenza vaccine immunogenicity in 6-to 23-month old children: are identical antigens necessary for priming? Pediatrics 2006; 118:e570-8.
30. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hem-agglutination-inhibition antibody titer as a correlated of vaccine-induced protection. J Infect Dis 2011; 204:1879-85.